Furthermore, by interrogating clinical data sets containing 959 breast cancer cases, we found that high expression of TCOF1 was significantly associated with tumour grade (p < 0.001) and TNM stage (p < 0.001) (Table S2), suggesting that TCOF1 may enhance tumour growth in TNBC patients. Here, TCOF1 is linked to breast carcinoma.